Figures & data
Table I. Physical properties of compounds 1a–f.
Figure 1 Dose-dependent inhibitory effect of benzimidazoles on H2O2-induced lipid peroxidation in erythrocyte membranes. Data are expressed as mean ± SE of 3–8 incubations.
![Figure 1 Dose-dependent inhibitory effect of benzimidazoles on H2O2-induced lipid peroxidation in erythrocyte membranes. Data are expressed as mean ± SE of 3–8 incubations.](/cms/asset/c589b63f-c0c1-4a76-bb83-0795b71d7c45/ienz_a_158586_f0002_b.gif)
Figure 2 In vitro effect of melatonin and benzimidazole derivatives on SOD activity from human erythrocytes. 1a-f was added at 0.5mM concentration to the incubation media. Values represent means from at least 3 different incubations ± SEM.
![Figure 2 In vitro effect of melatonin and benzimidazole derivatives on SOD activity from human erythrocytes. 1a-f was added at 0.5mM concentration to the incubation media. Values represent means from at least 3 different incubations ± SEM.](/cms/asset/f913d10a-5379-4393-a1c7-bc72bea30450/ienz_a_158586_f0003_b.gif)
Figure 3 In vitro effect of melatonin and benzimidazole derivatives on catalase activity from human erythrocytes. 1a-d was added at 0.5mM, 1e at 0.02mM and 1f at 0.01mM concentration to the incubation media. Values represent means from at least 3 different incubations ± SEM.
![Figure 3 In vitro effect of melatonin and benzimidazole derivatives on catalase activity from human erythrocytes. 1a-d was added at 0.5mM, 1e at 0.02mM and 1f at 0.01mM concentration to the incubation media. Values represent means from at least 3 different incubations ± SEM.](/cms/asset/2326c2f7-ba99-4761-80a8-31bca4a8d1cf/ienz_a_158586_f0004_b.gif)